Nuvectis Pharma NVCT
NASDAQ NVCT
$21.08 +0.16 (+0.76%)
At close: Nov 10, 2026 · 4:00 PM EST

Nuvectis Pharma (NVCT) Net Equity Issued and Repurchased (2021 - 2026)

Updated

Nuvectis Pharma's Net Equity Issued and Repurchased came in at $200,000 for Q2 2026, down 66.7% from $600,000 a year earlier.

Analysis

Nuvectis Pharma (NVCT) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Nuvectis Pharma reported Net Equity Issued and Repurchased of $14.26 million, down 37.6% year-over-year; for FY2025, it came in at $46.91 million, up 289.7% from FY2024.

  • Net Equity Issued and Repurchased carries a four-year compound annual growth rate of 32.4% (FY2021 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $12.04 million in FY2024 (+7.5%), $11.19 million in FY2023 (-30.1%), $16 million in FY2022 (+4.9%) and $15.25 million in FY2021.
  • The five-year range for quarterly Net Equity Issued and Repurchased is $7,000 (Q1 2026) to $16.8 million (Q1 2025).
  • Year-over-year, Net Equity Issued and Repurchased has declined for three consecutive quarters, with growth averaging 120.7% over the last six quarters.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q3 2025 (growth of 795.8%), and the weakest in Q1 2026 (a decline of 100.0%).
  • Business Quant data shows NVCT's Net Equity Issued and Repurchased at $7,000 (Q1 2026), $548,000 (Q4 2025) and $13.5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Nuvectis Pharma 724.92 Mn 505.25 Mn - -1.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -1.63 Mn
Jun 30, 2026 200,000.00
Mar 31, 2026 7,000.00
Dec 31, 2025 15.95 Mn
Sep 30, 2025 13.50 Mn
Jun 30, 2025 600,000.00
Mar 31, 2025 16.80 Mn
Dec 31, 2024 3.95 Mn
Sep 30, 2024 1.51 Mn
Jun 30, 2024 1.73 Mn
Mar 31, 2024 4.85 Mn
Dec 31, 2023 901,000.00
Sep 30, 2023 1.14 Mn
Jun 30, 2023 13.74 Mn
Mar 31, 2023 702,000.00
Sep 30, 2022 15.88 Mn
Mar 31, 2022 16.00 Mn
Sep 30, 2021 4.02 Mn
API Access

Nuvectis Pharma Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NVCT&period=max&api_key=YOUR_API_KEY